131 related articles for article (PubMed ID: 14651973)
21. Shuttle/sink model composed of β-cyclodextrin and simvastatin-loaded discoidal reconstituted high-density lipoprotein for enhanced cholesterol efflux and drug uptake in macrophage/foam cells.
He J; Yang Y; Zhou X; Zhang W; Liu J
J Mater Chem B; 2020 Feb; 8(7):1496-1506. PubMed ID: 31999290
[TBL] [Abstract][Full Text] [Related]
22. Plasmin and kallikrein reduce HDL-induced cholesterol efflux from foam cells.
Lindstedt L; Kovanen PT
Biochem Biophys Res Commun; 2000 Nov; 277(3):552-7. PubMed ID: 11061992
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity.
Salminen A; Åström P; Metso J; Soliymani R; Salo T; Jauhiainen M; Pussinen PJ; Sorsa T
FASEB J; 2015 Apr; 29(4):1435-45. PubMed ID: 25550459
[TBL] [Abstract][Full Text] [Related]
24. Triglyceride-rich lipoproteins inhibit cholesterol efflux to apolipoprotein (apo) A1 from human macrophage foam cells.
Palmer AM; Murphy N; Graham A
Atherosclerosis; 2004 Mar; 173(1):27-38. PubMed ID: 15177121
[TBL] [Abstract][Full Text] [Related]
25. β
Gao XQ; Li YF; Jiang ZL
Drug Des Devel Ther; 2017; 11():617-627. PubMed ID: 28424539
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol efflux from macrophages mediated by high-density lipoprotein subfractions, which differ principally in apolipoprotein A-I and apolipoprotein A-II ratios.
von Hodenberg E; Heinen S; Howell KE; Luley C; Kübler W; Bond HM
Biochim Biophys Acta; 1991 Nov; 1086(2):173-84. PubMed ID: 1932099
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine.
Voloshyna I; Hai O; Littlefield MJ; Carsons S; Reiss AB
Eur J Pharmacol; 2013 Jan; 698(1-3):299-309. PubMed ID: 23041272
[TBL] [Abstract][Full Text] [Related]
28. Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.
Hafiane A; Bielicki JK; Johansson JO; Genest J
PLoS One; 2015; 10(7):e0131997. PubMed ID: 26207756
[TBL] [Abstract][Full Text] [Related]
29. Mast cell proteases: physiological tools to study functional significance of high density lipoproteins in the initiation of reverse cholesterol transport.
Lee-Rueckert M; Kovanen PT
Atherosclerosis; 2006 Nov; 189(1):8-18. PubMed ID: 16530202
[TBL] [Abstract][Full Text] [Related]
30. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
Ohta T; Ikeda Y; Hattori S; Matsuda I
Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
[TBL] [Abstract][Full Text] [Related]
31. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
32. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol.
Tsujita M; Yokoyama S
Biochemistry; 1996 Oct; 35(40):13011-20. PubMed ID: 8855936
[TBL] [Abstract][Full Text] [Related]
34. Regulation of apolipoprotein E secretion by high density lipoprotein 3 in mouse macrophages.
Dory L
J Lipid Res; 1991 May; 32(5):783-92. PubMed ID: 2072040
[TBL] [Abstract][Full Text] [Related]
35. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification.
Nagano Y; Arai H; Kita T
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6457-61. PubMed ID: 1862074
[TBL] [Abstract][Full Text] [Related]
36. Lipid-sensing high-throughput ApoA-I assays.
Niedziela-Majka A; Lad L; Chisholm JW; Lagpacan L; Schwartz K; Hung M; Jin D; Fung W; Brendza KM; Liu X; Pagratis N; Sakowicz R
J Biomol Screen; 2012 Sep; 17(8):1050-61. PubMed ID: 22811478
[TBL] [Abstract][Full Text] [Related]
37. Reduced glutathione increases quercetin stimulatory effects on HDL- or apoA1-mediated cholesterol efflux from J774A.1 macrophages.
Rosenblat M; Volkova N; Khatib S; Mahmood S; Vaya J; Aviram M
Free Radic Res; 2014 Dec; 48(12):1462-72. PubMed ID: 25204422
[TBL] [Abstract][Full Text] [Related]
38. Epoxycholesterol impairs cholesteryl ester hydrolysis in macrophage foam cells, resulting in decreased cholesterol efflux.
Ouimet M; Wang MD; Cadotte N; Ho K; Marcel YL
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1144-50. PubMed ID: 18369155
[TBL] [Abstract][Full Text] [Related]
39. Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages.
Park SH; Kim JL; Kang MK; Gong JH; Han SY; Shim JH; Lim SS; Kang YH
Int J Mol Med; 2012 Nov; 30(5):1105-12. PubMed ID: 22922992
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein A-I stimulates secretion of apolipoprotein E by foam cell macrophages.
Rees D; Sloane T; Jessup W; Dean RT; Kritharides L
J Biol Chem; 1999 Sep; 274(39):27925-33. PubMed ID: 10488140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
